找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adult and Pediatric Neuromodulation; Jason P. Gilleran,Seth A. Alpert Book 2018 Springer International Publishing AG, part of Springer Nat

[復制鏈接]
樓主: 警察在苦笑
31#
發(fā)表于 2025-3-26 23:58:04 | 只看該作者
32#
發(fā)表于 2025-3-27 02:11:42 | 只看該作者
https://doi.org/10.1007/978-1-4302-2794-6nt option that has been studied extensively in patients with severe and refractory OAB. SNM significantly reduces urgency, frequency, and incontinence while also improving quality of life. Although SNM is not currently indicated for the treatment of OAB symptoms due to neurologic disease, recent lit
33#
發(fā)表于 2025-3-27 06:53:50 | 只看該作者
Interfacing to the Operating System, emptying can be found. This poses unique challenges to treating clinicians, and until recently, management was limited to physical therapy, assisted emptying with intermittent catheterization, foley catheter placement, or urinary diversion. Neuromodulation, in multiple forms, offers a minimally inv
34#
發(fā)表于 2025-3-27 10:11:31 | 只看該作者
Interfacing to the Operating System,tion system. PNE has been used since 1997 for the initial test phase and maintains many advantages. Advances in lead wire technology have increased the frequency of the initial test phase being performed in the operating room; however, this is an expensive and labor intensive technique. PNE is an of
35#
發(fā)表于 2025-3-27 14:14:42 | 只看該作者
36#
發(fā)表于 2025-3-27 20:27:14 | 只看該作者
https://doi.org/10.1007/978-1-4302-2794-6ctive bladder, non-obstructive urinary retention, and fecal incontinence. Since its introduction in the early 2000s, it continues to experience a “coming of age”. As a result, pudendal neuromodulation is perhaps settling into the unique role as an alternative approach to those who have failed sacral
37#
發(fā)表于 2025-3-27 22:57:07 | 只看該作者
38#
發(fā)表于 2025-3-28 05:21:57 | 只看該作者
39#
發(fā)表于 2025-3-28 09:25:25 | 只看該作者
Interfacing to the Operating System,tibial nerve at the ankle. PTNS is a minimally invasive technique that requires no permanent lead or implanted stimulator. It is currently approved by the United States Food and Drug Administration (FDA) for the treatment of overactive bladder (OAB) and its associated frequency, urgency, and urgency
40#
發(fā)表于 2025-3-28 14:01:10 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-6 12:30
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
鹤岗市| 锡林郭勒盟| 隆林| 昆明市| 丹巴县| 邛崃市| 西青区| 平乐县| 康保县| 赣榆县| 拜城县| 都安| 镇坪县| 禄劝| 寿宁县| 图木舒克市| 东乌珠穆沁旗| 临海市| 延长县| 稻城县| 宿松县| 新沂市| 澳门| 庆云县| 丰原市| 兴业县| 孙吴县| 中牟县| 湘潭市| 彭泽县| 芜湖市| 静乐县| 汉川市| 兴业县| 莱州市| 清流县| 鱼台县| 油尖旺区| 芦山县| 东宁县| 长宁区|